Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Manishi Prasad"'
Publikováno v:
The European Journal of Health Economics. 13:801-809
Golimumab is a novel TNF-α inhibitor licensed to treat patients with active PsA. Although its clinical efficacy has been proven in clinical trials, its cost effectiveness is yet to be established.To estimate the cost effectiveness of golimumab among
Autor:
Andrew Lloyd, Samir K. Bhattacharyya, Manishi Prasad, Ravinder Dhawan, Karin S. Coyne, Cheryl R. Dennison
Publikováno v:
PharmacoEconomics. 23:461-476
Constipation is a prevalent condition that disproportionately affects women and older adults and leads to self-medication and/or medical consultation. It occurs as a result of functional idiopathic causes or secondarily as a result of a variety of fa
Publikováno v:
PharmacoEconomics. 22:225-244
Health impairment often leads to work impairment in the form of both absenteeism and presenteeism (i.e. reduced productivity while at work). Several self-report productivity instruments have been designed over the past few years to measure the impact
Publikováno v:
Journal of medical economics. 16(3)
Many countries have various requirements for local economic analyses to assess the value of a new health technology and/or to secure reimbursement. This study presents a case study of an economic model developed to assess the cost-effectiveness of po
Autor:
Valery Walker, Melissa D. Johnson, Elizabeth Dodds Ashley, George Papadopoulos, Manishi Prasad, Dominika Dabrowski, Barbara D. Alexander, Richard H. Drew, John R. Perfect, Robert P. Danna
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Study Objective To determine the true institutional cost of treating invasive fungal infections in light of recent advances in diagnostic techniques and antifungal therapies for both treatment and prophylaxis of these infections. Design Economic anal
Publikováno v:
PharmacoEconomics. 21(11)
Gastro-oesophageal reflux disease (GORD) is common in the general population and is diagnosed based on patient-reported symptoms and clinical tests. Although clinical tests are available, significant percentages of patients report symptoms of heartbu
Publikováno v:
Clinical therapeutics. 24(4)
Background: The US Food and Drug Administration (FDA) recently held a meeting to determine whether the status of second-generation antihistamines (SGAs) should be switched from prescription (Rx) to over-the-counter (OTC) status. Objective: This artic
Autor:
Manishi Prasad, Lori Frank, Janice L. Krupnick, Dennis A. Revicki, Joyce Y. Chung, Jeanne Miranda, Juned Siddique, Bonnie L. Green
Publikováno v:
Archives of General Psychiatry. 62:868
Background Few clinical trials have evaluated interventions for major depressive disorder in samples of low-income minority women, and little is known about the cost-effectiveness of depression interventions for this population. Objective To evaluate
Publikováno v:
Cost Effectiveness and Resource Allocation. 3:5
Attention-deficit hyperactivity disorder (ADHD) is a common disorder that is associated with broad functional impairment among both children and adults. The purpose of this paper is to review and summarize available literature on the economic costs o
Publikováno v:
ACM Transactions on Accessible Computing; Sep2024, Vol. 17 Issue 3, p1-30, 30p